Diarrhea News and Research

Latest Diarrhea News and Research

Allergies may provide benefit by keeping away noxious environmental toxins

Yale researchers suggested Wednesday that allergies may be an outgrowth of the protective mechanism of the body to protect itself from noxious substances in the environment.

26 Apr 2012

'Global Pulse' summarizes event launching USAID child survival social media campaign

At an event on Monday launching USAID's "Every Child Deserves a Fifth Birthday" social media campaign, USAID Administrator Rajiv Shah described how $30 worth of materials contained in a backpack he carried onto stage, including zinc to prevent diarrhea and vaccines to prevent pneumococcal diseases, "can lead to a massive reduction in preventable child death in the developing world," GlobalPost's "Global Pulse" blog reports.

26 Apr 2012

Daily ART safe and effective in preventing mother-to-child HIV transmission

In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms or their breastfeeding babies for 28 weeks proved safe and effective for preventing mother-to-child HIV transmission through breast milk.

26 Apr 2012

Study finds negative health effects of anti-depressants

Commonly prescribed anti-depressants appear to be doing patients more harm than good, say researchers who have published a paper examining the impact of the medications on the entire body.

25 Apr 2012

Biogen Idec announces positive data from oral BG-12 second Phase 3 trial on RRMS

Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.

25 Apr 2012

USAID's Shah urges cooperation to improve child health, survival

"Seeing a child die from pneumonia, diarrhea or a mosquito bite is simply unimaginable to most parents. But that is the sad reality for many families each day," USAID Administrator Rajiv Shah writes in a Huffington Post Blog opinion piece, noting, "Last year over seven million children under five died of largely preventable causes."

24 Apr 2012

EMA CHMP recommends approval of AMAG’s ferumoxytol

AMAG Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron therapy, for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

21 Apr 2012

Bristol-Myers Squibb announces results from daclatasvir plus asunaprevir Phase II HCV study

Bristol-Myers Squibb Company today announced results from a Phase II study in which treatment with an all-oral, dual direct-acting antiviral (DAA) regimen of daclatasvir, an investigational NS5A replication complex inhibitor, and asunaprevir, an investigational NS3 protease inhibitor, achieved undetectable viral load 24 weeks post-treatment (SVR24) in 77% (33/43) of difficult-to-treat genotype 1b hepatitis C (HCV) patients.

20 Apr 2012

Final results from MSD’s VICTRELIS plus PEGINTRON Phase III trial on HCV treatment-related anemia

MSD, known as Merck in the United States and Canada, announced final results from a Phase III, open-label study designed to compare the impact of two anaemia management strategies on sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) genotype 1 infection treated with VICTRELIS(boceprevir) in combination with PEGINTRON and ribavirin.

20 Apr 2012

Inform Genomics completes first phase in oral mucositis risk prediction study

Inform Genomics, Inc., a private company focused on developing novel platforms of personalized medicine products for cancer supportive care and inflammatory diseases, today announced the completion of the first phase of product development to predict a patient's risk of developing oral mucositis after receiving high dose chemotherapy prior to hematopoietic stem cell transplant.

19 Apr 2012

Nigerian Vaccine Summit an opportunity to translate political will into action

In this post in the Huffington Post Blog, Orin Levine, executive director of the International Vaccine Access Center (IVAC), reports on the Nigerian Vaccine Summit, where Nigeria's leaders will meet this week to discuss children's health in the country.

18 Apr 2012

IMRT facilitates radiation dose escalation without compromising long-term morbidity for prostate cancer

In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.

18 Apr 2012

IMRT better than CRT for treatment of localized prostate cancer

A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, according to a study published in the April 18, 2012 issue of the Journal of the American Medical Association.

18 Apr 2012

UTHealth researcher studies novel cell therapy to prevent GVHD

A researcher at The University of Texas Health Science Center at Houston (UTHealth) is studying a novel cell therapy that could help avoid autoimmune problems after stem cell transplantation, as well as potentially treat other autoimmune diseases.

17 Apr 2012

Salmonella link with yellowfin tuna: mass recall follows

A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.

16 Apr 2012

Rotavirus infects certain blood types

Whether you become infected by some strains of rotavirus may depend on your blood type.

16 Apr 2012

Discontinuing antibiotic used to prevent opportunistic infections among HIV patients could increase risk of malaria, diarrhea

"Abruptly discontinuing co-trimoxazole -- an antibiotic used to prevent opportunistic infections in HIV-positive people -- can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.

12 Apr 2012

AstraZeneca introduces DUTOPROL for hypertension

AstraZeneca today announced the availability of DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL (metoprolol succinate) plus a low-dose diuretic that provides proven blood pressure lowering at 24 hours.

12 Apr 2012

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler.

From Quest Diagnostics 12 Apr 2012

GAVI Alliance secures deal to purchase rotavirus vaccines from GlaxoSmithKline, Merck

The GAVI Alliance "has struck a deal for bulk buying rotavirus shots from GlaxoSmithKline and Merck, which cuts the price by two-thirds and will allow poorer countries access to them at around $5 per course," Reuters reports.

12 Apr 2012

Diarrhea News and Research

Latest Diarrhea News and Research

Allergies may provide benefit by keeping away noxious environmental toxins

'Global Pulse' summarizes event launching USAID child survival social media campaign

Daily ART safe and effective in preventing mother-to-child HIV transmission

Study finds negative health effects of anti-depressants

Biogen Idec announces positive data from oral BG-12 second Phase 3 trial on RRMS

USAID's Shah urges cooperation to improve child health, survival

EMA CHMP recommends approval of AMAG’s ferumoxytol

Bristol-Myers Squibb announces results from daclatasvir plus asunaprevir Phase II HCV study

Final results from MSD’s VICTRELIS plus PEGINTRON Phase III trial on HCV treatment-related anemia

Inform Genomics completes first phase in oral mucositis risk prediction study

Nigerian Vaccine Summit an opportunity to translate political will into action

IMRT facilitates radiation dose escalation without compromising long-term morbidity for prostate cancer

IMRT better than CRT for treatment of localized prostate cancer

UTHealth researcher studies novel cell therapy to prevent GVHD

Salmonella link with yellowfin tuna: mass recall follows

Rotavirus infects certain blood types

Discontinuing antibiotic used to prevent opportunistic infections among HIV patients could increase risk of malaria, diarrhea

AstraZeneca introduces DUTOPROL for hypertension

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

GAVI Alliance secures deal to purchase rotavirus vaccines from GlaxoSmithKline, Merck

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Diarrhea News and Research

Latest Diarrhea News and Research

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in